Continuing Education Credit

An effort will be made to offer continuing education credits to the various health professionals attending the WPC 2010. Currently we are pursuing approval for the following:

°Continuing Medical Education Credits (CMEs)
European Accreditation
European Accreditation is granted by the EACCME in order to allow participants who attend the Second World Parkinson Congress to validate their credits in their own country.

Accreditation Statement
The 'World Parkinson Congress 2010 Limited' (or) 'Second World Parkinson Congress' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The 'Second World Parkinson Congress' is designated for a maximum of (or 'for up to') 24 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.

EACCME credits
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

°Continuing Education Units (CEUs) for Nurses
An application has been submitted to the American Association of Neuroscience Nurses (AANN) for approval of 30 contact hours. 

The American Association of Neuroscience Nurses is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's COA.


°Continuing Professional Development (CPDs) for Physiotherapists
The UK-based Chartered Society of Physiotherapists (CSP) does not have a CPD policy based on points or set hours.  The CSP along with the Health Professions Council (HPC), operate an outcomes based approach which means members/registrants are expected to demonstrate in writing the outcomes of learning rather than assume that learning has been undertaken by doing a set number of hours. 

The CSP advises the physiotherapists attending the WPC to evaluate the learning they think they have gained from the lecture(s), how they think they will apply this learning into their practice and to identify further gaps in their knowledge that may have become apparent as a result of what they have gained from the lecture(s). 

It is recommended that this form, which PTs may download here and copy or which they may pick up at the Continuing Education desk at the Congress, should be used to document the learning that takes place and kept on file as a record of attendance and educational learning.

 

World Parkinson Congress Learning Objectives

At the conclusion of the activity, participants should be able to:

  1. Discuss the role of genetics and environment as PD risk factors.
  2. List the distinguishing areas where research is exploring biomarkers.
  3. Describe the cell biological, neurochemical, neuropathological and neurophysiological aspects of PD.
  4. Identify the contributions of inflammation, protein mishandling and oxidative injury in the pathogenesis of PD.
  5. Identify experimental therapies for Parkinson's and expectations for future treatments.
  6. Explain the research and clinical criteria behind current work on neuroprotection for Parkinson's.
  7. List the spectrum of diseases within which PD fits.
  8. Explain conventional medical approaches and therapeutic options for the treatment of all stages of PD
  9. Describe surgical approaches and the patients most suitable for these treatment options.
  10. Discuss the intrinsic non-motor features of PD and their treatment options.
  11. Discuss the iatrogenic non-motor features of PD and their treatment options.
  12. Discuss the role of non-pharmacologic, complementary and alternative approaches in the care of PD patients.
  13. Explain the complications of medical therapy and approaches to management.
  14. Discuss the impact of Parkinsonism on disability and quality-of-life.
  15. Describe the relationship between public policy and health care delivery.
  16. Discuss the various models of interdisciplinary team care for persons affected by Parkinson's disease.
  17. Discuss the bio-psychosocial changes experienced by persons with PD and caregivers from early diagnosis to advanced stages and end of life.
  18. Articulate and understand the role of health care teams members, including nurses, occupational, speech and physical therapists, nutritionists, mental health experts and social workers in the treatment provided to those living with PD.
  19. Describe the spectrum of neuropsychiatric and cognitive changes in PD.
  20. Articulate and understand the multiple stressors experienced by family caregivers and the ways to provide care and support for this population.
  21. Describe challenges in the design and implementation of clinical trials for PD.


Faculty Financial Disclosure Information

The World Parkinson Congress aims to ensure balance, independence, objectivity and scientific rigor in all sponsored educational activities. To ensure this, all faculty participating in the WPC 2010 will be required to disclose to the audience any actual or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the Continuing Medical Educational (CME) or Continuing Education Unit (CEU) activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. Rather, the intention is for any potential conflict to be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains up to the audience to determine whether the speaker’s outside interest may reflect a possible bias in either the exposition or the conclusions presented.

Complete information regarding faculty disclosure of commercial relationships will be offered to each registrant in 2010..


Audience

The target audience of the WPC 2010 will include clinicians, researchers, post-doctoral fellows, allied health professionals, students, caregivers and people with Parkinson’s who have an interest in the current research and approaches for the diagnosis and best care practices of Parkinson’s disease.

 

 

Please Note

The WPC site has been optimized for accessibility. You are viewing this site in a standards non-compliant browser. While we have taken every step to ensure that you will still be able to easily navigate the full range of content, some of the site features, such as are related to accessiblity and the look-and-feel, may be considerably compromised. We encourage you to uprade to the latest version of your browser if possible. For your convenience, we are providing links to standards compliant browsers that are free for download. While we do not endorse the use of any one Web browser, we support the cause of complete web accessibility. If you have any problems viewing the site, or would like to make any suggestions, feel free to contact us.

Free Standards Compliant Web Browsers

  1. Mozilla Firefox
  2. Netscape Navigator
  3. Opera browser
  4. Internet Explorer